COSM
Price
$1.17
Change
-$0.08 (-6.40%)
Updated
Oct 16, 11:54 AM (EDT)
Capitalization
38.77M
Intraday Buy/Sell Signals
SUPN
Price
$49.52
Change
+$0.24 (+0.49%)
Updated
Oct 16, 12:21 PM (EDT)
Capitalization
2.76B
26 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

COSM vs SUPN

Header iconCOSM vs SUPN Comparison
Open Charts COSM vs SUPNBanner chart's image
Cosmos Health
Price$1.17
Change-$0.08 (-6.40%)
Volume$641
Capitalization38.77M
Supernus Pharmaceuticals
Price$49.52
Change+$0.24 (+0.49%)
Volume$100
Capitalization2.76B
COSM vs SUPN Comparison Chart in %
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COSM vs. SUPN commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COSM is a Hold and SUPN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (COSM: $1.25 vs. SUPN: $49.29)
Brand notoriety: COSM and SUPN are both not notable
COSM represents the Medical Distributors, while SUPN is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: COSM: 133% vs. SUPN: 77%
Market capitalization -- COSM: $38.77M vs. SUPN: $2.76B
COSM [@Medical Distributors] is valued at $38.77M. SUPN’s [@Pharmaceuticals: Generic] market capitalization is $2.76B. The market cap for tickers in the [@Medical Distributors] industry ranges from $98.5B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.93B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COSM’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 1 green FA rating(s).

  • COSM’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 1 green, 4 red.
According to our system of comparison, both COSM and SUPN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COSM’s TA Score shows that 5 TA indicator(s) are bullish while SUPN’s TA Score has 3 bullish TA indicator(s).

  • COSM’s TA Score: 5 bullish, 4 bearish.
  • SUPN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, COSM is a better buy in the short-term than SUPN.

Price Growth

COSM (@Medical Distributors) experienced а +17.92% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was +2.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +3.80%. For the same industry, the average monthly price growth was +4.43%, and the average quarterly price growth was +15.39%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.36%. For the same industry, the average monthly price growth was +7.32%, and the average quarterly price growth was +55.51%.

Reported Earning Dates

SUPN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Distributors (+3.80% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

@Pharmaceuticals: Generic (+0.36% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUPN($2.76B) has a higher market cap than COSM($38.8M). COSM YTD gains are higher at: 86.846 vs. SUPN (36.303). SUPN has higher annual earnings (EBITDA): 174M vs. COSM (-12.84M). SUPN has more cash in the bank: 523M vs. COSM (686K). COSM has less debt than SUPN: COSM (15.6M) vs SUPN (31.8M). SUPN has higher revenues than COSM: SUPN (665M) vs COSM (55.1M).
COSMSUPNCOSM / SUPN
Capitalization38.8M2.76B1%
EBITDA-12.84M174M-7%
Gain YTD86.84636.303239%
P/E RatioN/A42.86-
Revenue55.1M665M8%
Total Cash686K523M0%
Total Debt15.6M31.8M49%
FUNDAMENTALS RATINGS
COSM vs SUPN: Fundamental Ratings
COSM
SUPN
OUTLOOK RATING
1..100
578
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
10033
SMR RATING
1..100
9881
PRICE GROWTH RATING
1..100
3540
P/E GROWTH RATING
1..100
6100
SEASONALITY SCORE
1..100
5034

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SUPN's Valuation (78) in the Pharmaceuticals Other industry is in the same range as COSM (81) in the null industry. This means that SUPN’s stock grew similarly to COSM’s over the last 12 months.

SUPN's Profit vs Risk Rating (33) in the Pharmaceuticals Other industry is significantly better than the same rating for COSM (100) in the null industry. This means that SUPN’s stock grew significantly faster than COSM’s over the last 12 months.

SUPN's SMR Rating (81) in the Pharmaceuticals Other industry is in the same range as COSM (98) in the null industry. This means that SUPN’s stock grew similarly to COSM’s over the last 12 months.

COSM's Price Growth Rating (35) in the null industry is in the same range as SUPN (40) in the Pharmaceuticals Other industry. This means that COSM’s stock grew similarly to SUPN’s over the last 12 months.

COSM's P/E Growth Rating (6) in the null industry is significantly better than the same rating for SUPN (100) in the Pharmaceuticals Other industry. This means that COSM’s stock grew significantly faster than SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COSMSUPN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
60%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGLEX27.890.11
+0.40%
American Funds Global Insight R-4
APHLX15.610.04
+0.26%
Artisan Value Institutional
SETAX16.12N/A
N/A
SEI Real Estate F (SIMT)
NDVTX17.68N/A
N/A
MFS New Discovery Value R3
COSTX13.08N/A
N/A
Columbia Overseas Core Institutional 2

COSM and

Correlation & Price change

A.I.dvisor tells us that COSM and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COSM and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COSM
1D Price
Change %
COSM100%
+14.16%
YI - COSM
21%
Poorly correlated
-0.86%
SUPN - COSM
20%
Poorly correlated
+0.14%
OGI - COSM
16%
Poorly correlated
+3.68%
INCR - COSM
14%
Poorly correlated
-2.77%
ACB - COSM
13%
Poorly correlated
+2.56%
More

SUPN and

Correlation & Price change

A.I.dvisor tells us that SUPN and DRRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUPN and DRRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
+0.14%
DRRX - SUPN
32%
Poorly correlated
N/A
DVAX - SUPN
28%
Poorly correlated
+1.22%
SNDL - SUPN
27%
Poorly correlated
+1.64%
ACET - SUPN
27%
Poorly correlated
+2.52%
SILFF - SUPN
27%
Poorly correlated
N/A
More